Heterocyclic carboxylic acid ester derivative

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9346821
APP PUB NO 20140094489A1
SERIAL NO

14098774

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a blood glucose elevation inhibitor having a serine protease inhibitory action, which is a novel therapeutic or prophylactic agent for obesity. A compound represented by the following formula (I)

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
EA PHARMA CO LTD2-1-1 IRIFUNE CHUO-KU TOKYO 104-0042

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Koshiba, Takahiro Kawasaki, JP 13 79
Ohsumi, Koji Kawasaki, JP 32 358
Suzuki, Tamotsu Kawasaki, JP 89 676
Tokumasu, Munetaka Kawasaki, JP 22 227

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 24, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00